the results of longterm therapy with the oral gold preparation auranofin in patients with rheumatoid arthritis ( ra ) were evaluated based on the following data : 1 ) two multicenter open uncontrolled studies ( mtc06 ) and ( 162emua-ra ) , 2 ) the reevaluation of these data for the mtc06 study after 4 years from the beginning of the study and 3 ) the results of a postmarketing surveillance program ( pmsp ) of patients on auranofin therapy .
C0018026
gold
C0004320
auranofin